Long-Term Efficacy of Fremanezumab in Patients Who Reverted from a Chronic to an Episodic Migraine Classification

被引：0
|
作者：
Lipton, R. B.
Cohen, J. M.
Yang, R.
Seminerio, M. J.
Campos, V. Ramirez
Singh, R. B. Walker
Ailani, J.
机构：
来源：
HEADACHE | 2019年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P118
引用
收藏
页码：101 / 102
页数：2
相关论文
共 50 条
  • [1] Long-Term Efficacy of Fremanezumab in Patients Who Reverted From a Chronic to an Episodic Migraine Classification
    Lipton, Richard
    Cohen, Joshua
    Yeung, Paul P.
    Yang, Ronghua
    Seminerio, Michael
    Campos, Verena Ramirez
    Singh, Rashmi Halker
    Ailani, Jessica
    NEUROLOGY, 2019, 92 (15)
  • [2] Long-Term Impact of Fremanezumab on Headache-Related Disability and Quality of Life in Patients Who Reverted from a Chronic to an Episodic Migraine Classification
    Ailani, J.
    Cohen, J. M.
    Yugrakh, M. S.
    Ning, X.
    HEADACHE, 2019, 59 : 116 - 116
  • [3] Improvement in Response over Time with Fremanezumab in Patients Who Reverted from a Chronic to an Episodic Migraine Classification
    Singh, R. B. Halker
    Marmura, M. J.
    Cohen, J. M.
    Yang, R.
    HEADACHE, 2019, 59 : 108 - 108
  • [4] Improvement in Response Over Time With Fremanezumab in Patients Who Reverted From a Chronic to an Episodic Migraine Classification
    Singh, Rashmi Halker
    Marmura, Michael
    Cohen, Joshua
    Yeung, Paul P.
    Yang, Ronghua
    NEUROLOGY, 2019, 92 (15)
  • [5] Long-term Efficacy of Fremanezumab in Patients With Chronic or Episodic Migraine Who Were Inadequate Responders to Initial Fremanezumab Treatment
    Silberstein, Stephen D.
    Ortega, Mario
    Elms, Shawn
    Davis, Matthew
    Cohen, Joshua M.
    Seminerio, Michael
    Gross, Nick
    Blumenfeld, Andrew
    NEUROLOGY, 2021, 96 (15)
  • [6] Long-Term Impact of Fremanezumab on Headache-Related Disability and Quality of Life in Patients Who Reverted From a Chronic to an Episodic Migranie Classification
    Ailani, Jessica
    Cohen, Joshua
    Yugrakh, Marianna
    Yeung, Paul P.
    Ning, Xiaoping
    NEUROLOGY, 2019, 92 (15)
  • [7] Time Gained With Long-term Fremanezumab Treatment in Patients With Chronic and Episodic Migraine
    Marmura, M.
    Cohen, J. M.
    Ning, X.
    Campos, V. Ramirez
    Barash, S.
    Goadsby, P. J.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 174 - 174
  • [8] Time Gained With Long-term Fremanezumab Treatment in Patients With Chronic and Episodic Migraine
    Marmura, M.
    Cohen, J. M.
    Ning, X.
    Campos, V. Ramirez
    Barash, S.
    Goadsby, P. J.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1) : 117 - 117
  • [9] Reversion of Patients with Chronic Migraine to an Episodic Migraine Classification with Fremanezumab Treatment
    Singh, Halker R. B.
    Cohen, J. M.
    Bibeau, K.
    Galic, M.
    Seminerio, M. J.
    Campos, Ramirez, V
    Ailani, J.
    HEADACHE, 2018, 58 : 70 - 71
  • [10] Reversion of Patients with Chronic Migraine to an Episodic Migraine Classification with Fremanezumab Treatment
    Cohen, Joshua M.
    Bibeau, Kristen
    Galic, Maja
    Seminerio, Michael J.
    Ramirez-Campos, Verena
    Singh, Rashmi B. Halker
    Ailani, Jessica
    ANNALS OF NEUROLOGY, 2018, 84 : S183 - S184
12345